innovationtoronto.com
A new rapid-acting drug for depression is undergoing Phase 1 testing in human patients
A new small-molecule drug produced a rapid antidepressant response similar to that of ketamine when tested in mice, a new Yale-led study published April 16 in The Journal of Clinical Investigation …